MEDICLINIC INTERNATIONAL PLC

National Storage Mechanism | Additional information

RNS Number : 7064X

Mediclinic International PLC

23 February 2017

Mediclinic International plc

(Incorporated in England and Wales)

Company Number 8338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

LEI: 2138002S5BSBIZTD5I60

23 February 2017


TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:		Mediclinic International plc
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights			x
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation:	Coronation Asset Management (Pty) Ltd
4. Full name of shareholder(s) (if different from 3.):	N/A
5. Date of the transaction and date on which the threshold is crossed or reached:	23 February 2017
6. Date on which issuer notified:	23 February 2017
7. Threshold(s) that is/are crossed or reached:	3%


8. Notified details:
A: Voting rights attached to shares
Class/type of shares if possible using the ISIN CODE	Situation previous to the triggering transaction						Resulting situation after the triggering transaction
Number of Shares			Number of Voting Rights			Number of shares		Number of voting rights			% of voting rights
Direct		Direct		Indirect	Direct			Indirect
GB00B8HX8Z88	21 606 841			21 606 841			22 794 561		22 794 561			3.09%


B: Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument			Expiration date		Exercise/ Conversion Period					Number of voting rights that may be acquired if the instrument is exercised/ converted.				% of voting rights


C: Financial Instruments with similar economic effect to Qualifying Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument		Exercise price		Expiration date		Exercise/ Conversion period			Number of voting rights instrument refers to				% of voting rights
													Nominal		Delta


Total (A+B+C)
Number of voting rights								Percentage of voting rights
22 794 561								3.09%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:


Proxy Voting:
10. Name of the proxy holder:											Coronation Asset Management (Pty) Ltd
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:

13. Additional information:
14. Contact name:								Jamie Rowland
15. Contact telephone number:								+27 21 680 2000

Mediclinic's primary listing is on the Main Market of the LSE, with secondary listings on the JSE in South Africa and on the NSX in Namibia.

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Corporate broker: Morgan Stanley & Co International plc

JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

For further information please contact:

Mediclinic International plc

James Arnold, Head of Investor Relations

Capita Company Secretarial Services Limited

Victoria Dalby

+44 (0)207 954 9600

This information is provided by RNS

The company news service from the London Stock Exchange

END

HOLBDGDDSUDBGRX

AI Terminal